Fibrostenotic Inflammatory Bowel Disease | KitaabNow
Fibrostenotic Inflammatory Bowel Disease

Fibrostenotic Inflammatory Bowel Disease

 29,500
  • Edited By: Florian Rieder
  • ISBN: 9783319905778
  • Publisher: Springer Publishing Company
  • Edition: 1st
  • Publication Date: September 18, 2018
  • Format: Hardback – 397 pages
  • Language: English


Share
Description

This book provides a comprehensive account of the pathogenesis and treatment of intestinal fibrosis, covering both the clinical and molecular aspects of the disease. It begins by describing the epidemiology and genetics of fibrostenosing IBD in Crohn’s disease and Ulcerative colitis as well as the epigenetics and cellular and molecular mechanisms of the disease.

Readers will obtain an in-depth overview of the disease from biomarkers and histology to surgical intervention, imaging and current and future drug therapies. Medical management of fibrosis, endoscopy and imaging as well as surgical approaches are all discussed. Through the links to videos contained in the book, the reader will become familiar with interventional procedures such as endoscopic balloon dilation and surgical techniques for stricturing IBD, such as resection and strictureplasties. This is an indispensable volume for anyone working on fibrostenotic IBD, such as gastroenterologists, internists, radiologists, colorectal surgeons, pathologists and researchers. It has been written by a team of top experts from North America, Asia and Europe.

Key Features
  • Examines both pathophysiological and clinical aspects of the disease
  • Offers access to videos for medical and surgical intervention
  • Discusses current and future drug therapies
Table of Contents
  1. Foreword
  2. Fibrostenotic Inflammatory Bowel Disease – a Cinderella story
  3. Epidemiology and natural history of fibrostenosing IBD
  4. The genetics of IBD associated fibrosis
  5. Epigenetic regulation of intestinal fibrosis
  6. Anti-cytokine or growth factor therapy as a future therapeutic of fibrostenosing IBD
  7. Inflammation independent mechanisms of intestinal fibrosis
  8. Environmental factors and their influence on intestinal fibrosis
  9. Fat and fibrosis.- Sources of mesenchymal cells in intestinal fibrosis
  10. Animal models of intestinal fibrosis
  11. Mechanisms of resolution of intestinal fibrosis
  12. The intestinal mesenchymal cell and extracellular matrix as a pathogenetic factor in inflammation driven intestinal carcinogenesis
  13. Fibrosis in Ulcerative Colitis
  14. Histopathology of intestinal fibrosis
  15. Clinical, Cellular and Serologic Biomarkers of intestinal fibrosis
  16. Imaging in intestinal fibrosis – What is state or the art?
  17. The future of intestinal fibrosis imaging
  18. Medical therapy of stricturing IBD
  19. Endoscopic therapy of intestinal strictures – What is state of the art?
  20. The future of endoscopic therapy of intestinal strictures
  21. Surgical therapy of intestinal strictures – What is state of the art?
  22. The future of surgical therapy of structuring IBD
  23. Challenges of translation of anti-fibrotic therapies into clinical practice in IBD
  24. What distinguishes mechanisms of fistula and stricture formation
  25. The Pathogenesis of Intraabdominal Adhesions: Similarities and differences to luminal fibrosis
  26. Anti-fibrotic therapies from other organs – What the gut can learn from the liver, skin, lung and heart
Editor Biography

Dr. Rieder is a principal investigator at the Department of Inflammation and Immunity and an Associate Clinical Staff at the Department of Gastroenterology, Hepatology & Nutrition at the Cleveland Clinic, Cleveland. His focus is the field of pathogenesis, prediction and therapy of intestinal fibrosis. He is a fully trained Internist and Gastroenterologist with an IBD focussed clinical and endoscopic practice. He initiated and organized international clinical consensus meetings. Dr. Rieder published more than 70 articles and book chapters in high impact journals, including Science Translational Medicine, Gastroenterology and Gut. He has been recognized for his expertise as indicated through invitations to the steering committee of the 2nd European Crohn’s and Colitis Organization (ECCO) scientific workshop on ‘Intestinal healing’, group leader of the 4th ECCO scientific workshop on ‘Intestinal fibrosis’, invitations as a full member of the consensus panel of the ECCO guidelines on Crohn’s disease, lead author of the ECCO guidelines on Ulcerative colitis and lead author of the first ECCO clinical consensus on ‘Diagnosis and Management of Intestinal Fibrosis’ as well as multiple international invitations as a speaker, session chair or conference faculty.

Additional information
Weight 0.958 kg
Reviews

There are no reviews yet.

Be the first to review “Fibrostenotic Inflammatory Bowel Disease”

Menu
Categories
*Data Not Found